Applying Network Meta-Analysis to Cardiovascular Outcome Trials of Glucose-Lowering Drugs

被引：1
|
作者：
Zheng, Sean L. [1 ]
Roddick, Alistair J. [1 ]
机构：
[1] Imperial Coll London, Dept Cardiol, Fac Med, Kings Coll Hosp NHS Fdn Trust, 33 Willcott Rd, London SE5 9RS, England
来源：
JACC-HEART FAILURE | 2018年 / 6卷 / 12期
关键词：
D O I：
10.1016/j.jchf.2018.09.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1052 / 1052
页数：1
相关论文
共 50 条
  • [21] GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS
    Palmer, Suetonia
    Mavridis, Dimitris
    Nicolucci, Antonio
    Craig, Jonathan
    Tonelli, Marcello
    Johnson, David
    De Berardis, Giorgia
    Ruospo, Marinella
    Natale, Patrizia
    Saglimbene, Valeria
    Badve, Sunil
    Cho, Yeoungjee
    Nadeau-Fredette, Annie-Claire
    Burke, Michael
    Faruque, Labib
    Lloyd, Anita
    Ahmad, Nasreen
    Tiv, Sophanny
    Liu, Yuanchen
    Wiebe, Natasha
    Strippoli, Giovanni
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [22] Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
    Zaccardi, Francesco
    Kloecker, David E.
    Buse, John B.
    Mathieu, Chantal
    Khunti, Kamlesh
    Davies, Melanie J.
    DIABETES CARE, 2021, 44 (02) : E32 - E34
  • [23] Mortality Risk of Noninsulin Glucose-Lowering Drugs in Type 2 Diabetes-A Network Meta-analysis of Observational Trials
    Bongaerts, Brenda
    Lindner, Lena M.
    Hoyer, Annika
    Kuss, Oliver
    Herder, Christian
    Al-Hasani, Hadi, Sr.
    Mussig, Karsten
    Roden, Michael
    Rathmann, Wolfgang
    DIABETES, 2018, 67
  • [24] Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
    Udell, Jacob A.
    Cavender, Matthew A.
    Bhatt, Deepak L.
    Chatterjee, Saurav
    Farkouh, Michael E.
    Scirica, Benjamin M.
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (05): : 356 - 366
  • [25] Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials
    Seidu, S.
    Achana, F. A.
    Gray, L. J.
    Davies, M. J.
    Khunti, K.
    DIABETIC MEDICINE, 2016, 33 (03) : 280 - 289
  • [26] Renal outcomes associated with glucose-lowering agents: Systematic review and meta-analysis of randomized outcome trials
    Chalmoukou, Konstantina
    Polyzos, Dimitris
    Manta, Eleni
    Tatakis, Fotis
    Konstantinidis, Dimitris
    Thomopoulos, Costas
    Costas, Tsioufis
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 97 : 78 - 85
  • [27] Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes
    Yudkin, John S.
    Vijan, Sandeep
    Sussman, Jeremy B.
    Lehman, Richard
    Goldacre, Ben M.
    LANCET, 2014, 384 (9948): : 1095 - 1095
  • [28] Cardiovascular outcome trials of glucose-lowering drugs in type 2 diabetes: 10 frequently asked questions
    George, Jyothis T.
    PRACTICAL DIABETES, 2015, 32 (08) : 301 - 304
  • [29] Comparison of New Glucose-Lowering Drugs on the Risk of Pancreatitis in Type 2 Diabetes: A Network Meta-Analysis
    Zhang, Xuexue
    Wang, Miaoran
    Wang, Xujie
    Zhu, Zhengchuan
    Zhang, Wantong
    Zhou, Zhongyang
    Tang, Wei
    Li, Qiuyan
    ENDOCRINE PRACTICE, 2022, 28 (03) : 333 - 341
  • [30] Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes A Systematic Review and Network Meta-analysis
    Tsapas, Apostolos
    Avgerinos, Ioannis
    Karagiannis, Thomas
    Malandris, Konstantinos
    Manolopoulos, Apostolos
    Andreadis, Panagiotis
    Liakos, Aris
    Matthews, David R.
    Bekiari, Eleni
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (04) : 278 - +
12345